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1. Introduction
  Epithelial-mesenchymal transition (EMT) was first 
proposed by Greenberg and Hay in 1982, who found 
that the lens epithelial cells cultured in the gel can 
morphologically transform into the mesenchyme-like 
cells with pseudopodia[1]. EMT persists throughout the 
mammalian embryonic development and also exists in the 
pathophysiological processes including tissue healing, organ 
fibrosis and tumor cell infiltration and metastasis. EMT is 
mainly characterized by loss of epithelial cell polarity, gain 
of mesenchymal cell properties, and abnormal expression of 
E-cadherin and N-cadherin. Transforming growth factor-
毬1 (TGF-毬1) is considered the master molecule in the 
genesis of EMT in mammals[2]. Twist is a basic helix-
loop-helix transcription factor and plays a critical role 
in the regulation of EMT[3]. Prostate cancer is a common 
malignant tumor in the urinary system and its mortality 
rate ranks second, only after lung cancer, among all 
malignant tumors in Europe and America[4,5]. Recently, with 
acceleration of aging process, changes in life style and diets 
and improvement in diagnostic technique, the incidence 
of prostate cancer in gradually increasing in China. In 
prostate cancer patients, cancer cells easily separate from 
primary foci because of poor cell-cell adhesion and invade 
adjacent tissue and organs, leading to metastasis of lymph 
nodes, bone or distal organs and finally resulting in a high 
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malignant potential with poor biological behaviors and 
prognosis. To validate whether prostate cancer acquires its 
highly invasive malignant biological behaviors via EMT, 
we detected the expression levels of EMT related proteins 
including E-cadherin, N-cadherin, TGF-毬1 and Twist1 in 
prostate cancer tissue and adjacent tissue and investigated 
the role and significance of EMT in the incidence and 
development of prostate cancer. 
2. Materials and methods 
2.1. Experimental specimens
  Tissue specimens were harvested from 59 patients who 
underwent radical prostatectomy or prostate puncture in our 
Hospital from 2008 to 2011 and pathologically diagnosed as 
primary prostate cancer. Simultaneously, tissues around the 
prostate cancer foci were harvested from 21 prostate cancer 
patients as controls. The patients who received anti-tumor 
treatments prior to surgery were not included in this study. 
The included average age of prostate cancer patients were 68 
(range, 55-84) years old. According to the Gleason grading 
system, prostate cancer can be classified, with a score of 
2-4 being well differentiated, 5-7 moderately differentiated 
and 8-10 poorly differentiated. The selected prostate cancer 
specimens consisted of well differentiated (n=18), moderately 
differentiated (n=22) and poorly differentiated cancer tissues 
(n=19). Serum prostate-specific antigen (PSA) was < 10 毺g/L
(n=8), 10-20 毺g/L (n = 13) and > 20 毺g/L (n=38). The 
Whitmore-Jewett staging system was used for grading 
experimental specimens. Stage A, cancer cells were found 
only in pathological examination; stage B, positive clinical 
symptom and cancerous tubercle only in the prostate gland; 
stage C, tumor cells have spread outside the covering of the 
prostate gland to tissues around the prostate gland but not to 
the lymph nodes; stage D, cancer cells have metastasized. 
  According to the known data (preoperative: B ultrasound 
images, pelvic CT and MRI images, bone scanning images of 
the whole body, chest X-ray image; intraoperative records: 
tumor size and morphology, tumor cell invasion or not, pelvic 
lymph node swelling or not; postoperative: pathological 
results), 59 patients with prostate cancer were categorized 
according to their clinical stages: 26 patients in stages A, 
B, 14 patients in stage C, and 19 patients in stage D. Among 
these included patients with prostate cancer, 27 underwent 
radical prostatectomy, 15 medical castration combined with 
antiandrogen treatment, 9 bilateral orchidectomy combined 
with antiandrogen treatment, 5 transurethral resection of 
the prostate gland and 3 underwent only prostatic puncture 
without any other treatments.
2.2. Main reagents
  Rabbit anti-human E-cadherin polyclonal antibody 
(dilution 1:50) was purchased from Bioss Biotechnology 
Co.,Ltd., Beijing, China; rabbit anti-human N-cadherin 
(dilution 1:50), TGF-毬1 (dilution 1:100) and Twist polyclonal 
antibodies (dilution 1:100) were purchased from Santa Cruz 
Biotechnology, Santa Cruz, CA, USA. Immunohistochemical 
SABC reagent kit, DAB and secondary antibodies were 
purchased from Boster, Wuhan, China.
2.3. Methods
  According to kit instructions, experiments were performed 
using immunohistochemical SABC method. Precisely, 
paraffin specimens were sliced into 4毺m sections, toasted 
at 60 ℃ in the thermostat oven, de-waxed by xylene, and 
dehydrated through ethanol series (60%-100%). After PBS 
(pH=7.4) washes, the sections were treated with 3% H2O2 to 
inactivate endogenous peroxydase and with 0.01 M sodium 
citrate solution (pH=6.0) for microwave antigen retrieval. 
Subsequently, the sections were blocked with 10% normal 
goat serum and treated with primary antibody at 4 ℃ 
overnight. After PBS (pH=7.4) washes, the sections were 
incubated at 37 ℃ after addition of secondary antibodies, 
treated with SABC solution, developed with DAB, slightly 
counterstained with hematoxylin, routinely dehydrated, 
mounted and finally observed under the microscope. 
Positive control images were provided by Boster, Wuhan, 
China. PBS, rather than primary antibody, was used as a 
negative control.  
2.4. Result evaluation 
  E-cadherin-positive cells exhibited yellow or dark brown 
particles in the cellular membrane. Under 400-fold optical 
microscope, E-cadherin-positive cells in five different 
fields of view were counted. The results were evaluated 
according to the percentage of E-cadherin-positive cells in 
total cells: ≥ 90% indicates E-cadherin-positive expression 
and <90% E-cadherin-negative expression. 
  N-cadherin-positive cells exhibited yellow or dark brown 
particles in the cytoplasm (or) cellular membrane. According 
to the method described by Lascombe et al[6], results were 
evaluated using semi-quantitative method: the percentage 
of positive cells ≥5% indicates N-cadherin-positive 
expression and <5% N-cadherin-negative expression. 
  TGF-毬1-, Twist-positive cells exhibited dark brown 
particles in the cytoplasm and (or) a small number of nuclei. 
Semi-quantitative integration was used for grading TGF-毬
1-, Twist expression based on positive cell percentage and 
staining intensity. The positive cell percentage was scored 
0-3 from < 5%, 5%-25%, 26%-75%, to > 75% in order. The 
staining intensity was scored 0-2 from none, faint to strong 
staining in order. The grading criteria for TGF-毬1 and 
Twist expression was determined by the scores given as the 
sum of positive cell percentage and staining intensity scores: 
≤ 1.9 points being“-”, 2-2.9 being “+”, 3-3.9 points being 
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“++”, ≥ 4 points being “+++”. “-, +” was designated as 
low expression (negative), and “++, +++” as high expression 
(positive). 
2.5. Statistical analysis
  All data were statistically processed using SPSS13.0 
software. Comparisons of E-cadherin, N-cadherin, TGF-毬
1 and Twist expression among groups were performed using 
x2 test or x2 trend test and Yates was used when necessary. 
Correlations among E-cadherin, N-cadherin, TGF-毬1 
and Twist expression was analyzed with Spearman’s rank 
correlation. A level of P<0.05 was considered statistically 
significant. 
3. Results 
3.1. E-cadherin expression
  E-cadherin was normally expressed in the cellular 
membrane. E-cadherin expression was significantly lower in 
the prostate cancer tissue than in the adjacent tissue [32.2% 
(19/59) vs. 85.27% (18/21), P<0.05; Table 1]. The expression 
rate of N-cadherin-positive cells in the well differentiated, 
moderately differentiated and poorly differentiated groups 
was 50.0%, 31.8% and 15.8%, respectively, showing a 
decreasing tendency (x2trend=4.87, P<0.05). E-cadherin 
expression was significantly lower in the serum PSA >20 毺g/L
group than in the serum PSA≤20 毺g/L group (P<0.05). 
E-cadherin expression was not correlated with the clinical 
pathological factors including clinical stage, age, lymph 
node metastasis or bone metastasis (P>0.05; Table 2). 
3.2. N-cadherin, TGF-毬1 and Twist expression 
  N-cadherin was mainly expressed in the cytoplasm and 
cellular membrane (Figure 1). N-cadherin expression was 
significantly higher in the prostate cancer tissue than in 
the adjacent tissue (54.2% vs. 9.52%, P<0.05). TGF-毬1 was 
mainly expressed in the cytoplasm and scattered in the 
nucleus (Figure 2). TGF-毬1 expression was significantly 
higher in the prostate cancer tissue than in the adjacent 
tissue (71.2% vs. 19%, P<0.05). Twist was mainly expressed 
in the cytoplasm and scattered in the nucleus (Figure 3). 
Twist expression was significantly higher in the prostate 
cancer tissue than in the adjacent tissue (74.6% vs. 9.52%, 
P<0.05; Table 1). With decrease in degree of differentiation 
of prostate cancer cells, N-cadherin, TGF-毬1, Twist 
expression tended to be increased (x2trend = 4.47, P<0.05; x2 
trend = 6.88, P<0.05; x2 trend = 7.38, P<0.05). N-cadherin, 
TGF-毬1 and Twist expression rates were significantly 
lower in the stages A, B than in the stages C, D (P<0.05), 
significantly higher in patients with lymph node metastasis 
than in patients without (P<0.05), and significantly higher 
in patients with bone metastasis than in patients without
(P < 0.05). N-cadherin, TGF-毬1 and Twist expression did 
not correlate with patient’s age (P>0.05). N-cadherin and 
TGF-毬1 expression rates were significantly higher in the 
serum PSA > 20 毺g/L group than in the serum PSA ≤ 20 
Table 1
Comparisons of E-cadherin, N-cadherin, TGF-毬1 and Twist expression in the prostate cancer tissue and adjacent tissue. 
Protein 
Prostate cancer tissue (n=59)        Adjacent tissue (n=21)
x2 P
Positive Negative Positive Negative 
E-cadherin 19 40 18   3 17.84 0.000
N-cadherin 32 27   2 19 12.67 0.000
TGF-毬1 42 17   4 17 17.23 0.000
Twist 44 15   2 19 26.82 0.000
Table 2
Correlations of E-cadherin, TGF-毬1, N-cadherin and Twist expression levels in the prostate cancer tissue and clinical pathological factors. 
Pathological factors n
E-cadherin N-cadherin TGF-毬1 Twist
Positive x2 P Positive x2 P Positive x2 P Positive x2 P
Pathological grade Highly differentiation 18   9 0.027   6 0.035   9 0.009   9 0.007
Media differentiated 22   7 13 16 16
Low differentiated 19   3 13 17 17
PSA  ≤20毺g/L 21 14 17.74 0.000   6 8.65 0.030   8 17.41 0.000   8 2.76 0.097
>20毺g/L 38   5 26 34 34
Clinical stage A, B stage 26 10   0.83 0.361 10 4.66 0.031 14   6.81 0.009 14 6.99 0.008
C, D stage 33   9 22 28 28
Lymphatic metastasis yes 17   4   0.82 0.364 13 4.76 0.029 16   4.65 0.031 16 6.37 0.012
no 42 15 19 26 26
Osseous metastasis yes 14   3   0.44 0.509 11 4.38 0.036 14   5.72 0.017 14 4.62 0.032
no 45 16 21 28 28
Age (Years old) ≤68 28   6   2.83 0.092 18 2.17 0.141 22   1.41 0.234 22 1.27 0.260
>68 31 13 14 20 20
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毺g/L group (P<0.05). There was no significant difference in 
Twist expression between serum PSA > 20 毺g/L group and 
serum PSA ≤ 20 毺g/L group (P>0.05; Table 2). 
 
Figure 1. N-cadherin-positive expression in the prostate cancer 
tissue (SABC, ×400).
 
Figure 2. TGF-毬1-positive expression in the prostate cancer tissue 
(SABC, ×400).
 
Figure 3. Twist-positive expression in the prostate cancer tissue 
(SABC, ×400).
3.3. Correlations among E-cadherin, N-cadherin, TGF-毬1 
and Twist expression in the prostate cancer tissue 
  Spearman’s rank correlation analysis of E-cadherin, 
N-cadherin, TGF-毬1 and Twist expression in the prostate 
cancer tissue was performed using SPSS 13.0 for windows 
software. E-cadherin expression was negatively correlated 
with N-cadherin expression (r=-0.532, P<0.05), Twist 
expression negatively correlated with E-cadherin expression 
(r=-0.681, P<0.05), TGF-毬1 expression negatively 
correlated with E-cadherin expression (r=-0.362, P=0.005), 
and TGF-毬1 expression was positively correlated with 
N-cadherin (r=-0.392, P=0.002) and Twist expression (r=-
0.488, P=0.000). However, there was no correlation between 
Twist and N-cadherin expression (r=-0.245, P=0.061) (Table 
3, 4). 
Table 3
Correlation of E-cadherin and N-cadherin in the prostate cancer 
tissue (n).
E-cadherin
N-cadherin
Total 
+ -
+   3 16 19
- 29 11 40
Total 32 27 59
Table 4
Correlation of Twist and E-cadherin in the prostate cancer tissue (n).
Twist
E-cadherin
Total
+ -
+   6 38 44
- 13   2 15
Total 19 40 59
4. Discussion
  Human E-cadherin coding gene is located on chromosome 
16 at position 22.1, with a protein molecular weight of 120 
kD, which contains 723-748 amino acids. Its molecular 
structure is composed of an intracellular C-end domain, 
an extracellular N-end domain and a hydrophobic 
transmembrane domain. The intracellular C-end domain 
binds to catenin to form functional cadherin-catenin 
complex, which stabilizes E-cadherin on the cytoskeleton. 
The extracellular N-end domain identifies and mediates 
cell-cell adhesion through the His-Ala-Val structure. 
Down-regulation or loss of E-cadherin expression inevitably 
decreases the stability between epithelial cells and disturbs 
cell polarity. For this reason, downregulated E-cadherin 
expression is considered a marker of the occurrence of 
EMT. A previous report[7] reported that downregulation of 
E-cadherin expression in the epithelial tumor tissue is 
common and correlates with tumor grading. Strong evidence 
exists that E-cadherin expression basically disappears or is 
greatly downregulated in poorly differentiated tumor cells, 
such as breast cancer[8], stomach cancer[9], liver cancer[10] 
and rectal cancer[11]. Results from this study showed that 
E-cadherin expression was significantly lower in the prostate 
cancer tissue than in the adjacent tissue (P<0.05), and it 
was closely related to the degree of tissue differentiation 
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(P<0.05) but not related to clinical stage, lymph node or 
bone metastasis and patient’s age (P>0.05). At present, 
the expression and significance of E-cadherin in the 
prostate cancer tissue remains controversial. The possible 
mechanism is that in the early stage prostate cancer tissue, 
downregulated E-cadherin expression inevitably decreases 
cell-cell stability, leading to desquamation of an increased 
proportion of local cells and easily resulting in tumor cell 
infiltration and metastasis; however, after infiltration and 
metastasis, tumor cells colonize and grew in a new area, 
during which, E-cadherin expression is needed, and tumor 
cells likely re-express prior downregulated E-cadherin 
to promote the growth and expansion of metastatic tumor 
cells in the newly colonized area. Therefore, E-cadherin 
expression is different in different developmental periods 
of prostate cancer. Results from this study also showed 
that a small number of prostate cancer cells expressed 
E-cadherin in the cellular membrane, and the expression 
is largely in the cytoplasm. This occurs possibly because 
the prostate cancer cell can still synthesize E-cadherin, but 
the formation of E-cadherin-catenin complex is inhibited, 
distributing the normal expression of E-cadherin in the 
cellular membrane. Gottardi et al[12] reported that catenin 
exists in the rectal cancer cells in two forms: one form is to 
form complex with cadherin and the other form is to bind to 
T cell factors to activate catenin and inhibit the formation 
of E-cadherin-catenin complex. However, whether this 
mechanism is also behind the prostate cancer cells requires 
further investigation. 
  N-cadherin, with encoding gene on chromosome 18 at 
position 11.2 and a protein molecular weight of 127 kD, 
is only expressed in neuroectodermal and mesodermic 
tissues, for example, mature muscle, nerve and hemopoietic 
tissue but hardly expressed in the normal epithelial cells. 
N-cadherin expression in the epithelial tissue can alter the 
normal morphology and biological behavior of the epithelial 
cells and transform epithelial cells into mesenchyme-
like cells, i.e., the occurrence of EMT. Results from in 
vitro experiments[13,14]  have shown that after successfully 
transfecting N-cadherin into the cancer cells that do not 
express N-cadherin, the invasive ability of the cancer 
cells is significantly increased. In a breast cancer cell 
experiment, Hazan et al[15] found that application of anti-
N-cadherin antibody can effectively reduce the migration 
of breast cancer cells across the vascular endothelium, and 
compared to low E-cadherin expression, high N-cadherin 
expression more directly promotes the progression of EMT. A 
previous study[16] reported that N-cadherin can help cancer 
cells to escape from the primary foci and promote cancer 
cells to adhere to extracellular matrix or endothelium, 
playing an important role in the infiltration and metastasis of 
tumor cells. Gwak et al[17] found that N-cadherin resists the 
apoptosis of tumor cells and thereby participates in tumor 
progression. The above findings suggest that N-cadherin is 
closely related to tumor cell infiltration and metastasis and 
pathological grades. In this study, we detected N-cadherin 
expression in the prostate cancer tissue and adjacent tissue 
at different developmental periods of prostate cancer and our 
results are consistent with above findings. Our results also 
showed that both E-cadherin and N-cadherin expression is 
related to serum PSA level. When serum PSA level is > 20 毺g/L,
E-cadherin expression is decreased while N-cadherin 
expression is increased. Serum PSA is an important index 
of detecting prostate cancer and patients with higher level 
of serum PSA exhibit poorer prognosis than patients with 
lower level of serum PSA[18]. We considered that decreased 
E-cadherin expression and abnormal N-cadherin expression 
decrease cell-cell adhesion, destroy cell morphology and 
integrity, and alter prostate cell permeability, which may 
contribute to the increase in serum PSA level, further 
revealing that these changes are related to the occurrence of 
prostate cancer. 
  E-cadherin and N-cadherin are typical cadherins, but 
these two exert opposite roles during the metastasis of tumor 
cells. The precise mechanism has not been fully understood. 
Hazan et al[19] proposed the hypothesis “cadherin switch” 
and considered that “cadherin switch” is one of important 
mechanisms underlying EMT. “Cadherin switch” refers 
to cadherin transformation from type E to type N during 
normal cell transformation into malignant cells. Results from 
this study have demonstrated that with the decrease in the 
degree of differentiation of prostate cancer cells, E-cadherin 
expression is significantly decreased while N-cadherin 
expression is significantly increased (P<0.05). Spearman’s 
rank correlation analysis results showed that E-cadherin 
expression was highly negatively correlated with N-cadherin 
expression, indicating that the cadherin indeed switches 
from E-cadherin to N-cadherin in prostate cancer.  
  TGF-毬 can inactivate macrophages by directly inhibiting 
the formation of reactive oxygen and the intermediate 
products and indirectly antagonizing the effects of tumor 
necrosis factor-毭 and tumor necrosis factor-毩 on 
macrophages. Reactive oxygen and the intermediate 
products exhibit very important role in the immunological 
function of macrophages and can be upregulated by tumor 
necrosis factor-毭 and tumor necrosis factor-毩. TGF-
毬 regulates T cell immunologic response by inhibiting the 
proliferation and function of lymphocytes. TGF-毬 better 
inhibits the proliferation of mature or activated T cells and 
it mainly inhibits anti-CD3 antibody or mitogen-activated T 
cells by downregulating interleukin-2 expression. TGF-毬 
can increase the sensitivity to apoptosis of T cells activated 
in the early stage and induce the growth retardation of T 
cells and the accumulation of G1 stage cells. TGF-毬 can 
downregulate the expression of human leukocyte antigen-
DR, decrease the expression of interleukin-1 and tumor 
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necrosis factor-毩 in monocytes and simultaneously 
decrease the expression of interleukin-1 receptor and 
interleukin-1 receptor antagonist. TGF-毬 can inhibit the 
formation of tumor necrosis factor-毭generated by the 
T cells stimulated. Therefore, TGF-毬 is considered to 
have obvious double-sided effects in the occurrence and 
development of tumors. TGF-毬1, an important member 
of TGF-毬 superfamily, can promote the infiltration and 
metastasis of tumor cells, but the precise mechanism has not 
been fully clarified. A previous study regarding pancreatic 
cancer cells[20] reported that TGF-毬1 promotes N-cadherin 
expression but it inhibits E-cadherin expression. Results 
from this study showed that TGF-毬1 expression was 
significantly higher in the prostate cancer tissue than in the 
adjacent tissue; TGF-毬1 expression was increased with 
decrease in degree of differentiation of tumor cells, increase 
in clinical stage, and lymph node or bone metastasis; 
moreover, TGF-毬1 expression was positively correlated 
with N-cadherin expression and negatively correlated with 
E-cadherin. In addition, the present results also showed 
that TGF-毬1 expression was increased when serum PSA 
level was > 20 毺g/L. TGF-毬1 can stimulate osteoblasts 
and promote bone metastasis, and there is an increased risk 
of bone metastasis when serum PSA level is 20 毺g/L[21].
In this study, serum PSA level > 20 毺g/L appeared in 
14 patients and TGF-毬1 expression was all positive, so 
serum PSA level > 20 毺g/L was a possible marker of bone 
metastasis. Taken together, TGF-毬1 exhibits a promoting 
effect in the occurrence of prostate cancer and subsequent 
infiltration and metastasis of tumor cells, indicating that 
TGF-毬1 can be taken as an important index of determining 
the progression and prognosis of prostate cancer. 
  Recently, great importance has been continuously 
attached to EMT in the infiltration and metastasis of tumor 
cells and Twist has been a new exciting field. Twist is 
generally acknowledged to be an oncogene protein. It 
directly inhibits E-cadherin expression by regulating 
E-box in the E-cadherin promoter region and thereby 
induces the occurrence of EMT[22]. Evidence exists that 
TGF-毬 participates in Twist promotion of EMT via PI3K/
AKT pathway, RAS/MAPK pathway and SAMD pathway. 
Therefore, Twist likely plays a central action in the process 
of EMT. Previous studies have demonstrated that Twist 
is highly expressed in various tumors, such as breast 
cancer[23], nasopharyngeal cancer[24], bladder cancer[25] and 
melanoma[26]. The mechanisms by which Twist promotes 
the occurrence and development of tumors are as follows: 
Twist starts EMT, inhibits cell apoptosis via encoding 
inhibitor of apoptosis protein, interferes P53 pathway, 
inhibits P21 gene and promotes tumor angiogenesis. Yang 
et al[27] found that Twist is highly expressed during the 
process of metastasis of tumor cells and plays an important 
role in intravascular infiltration and distal metastasis 
of cancer cells and that getting rid of Twist expression 
by RNA interference technology greatly decreases the 
velocity of cancer cells entering into the blood circulation 
and the number of cancer cells that transfer to the lung. 
Immunohistochemical detection results from this study 
showed that Twist was highly expressed in the prostate 
cancer tissue and the expression difference was statistically 
significant under different clinical pathological factors 
related to prostate cancer, in terms of the degree of tissue 
differentiation, clinical stage, lymph node metastasis, and 
bone metastasis; Spearman’s rank correlation results showed 
that Twist expression was highly negatively correlated with 
E-cadherin expression and TGF-毬1 expression was highly 
positively correlated with Twist expression. The present 
results are consistent with above-mentioned viewpoint. 
Our results suggest that high Twist expression indicates the 
malignant metastasis of tumor cells and is one of signals for 
poor prognosis. Because Twist expression is closely related 
to the pathological factors of prostate cancer, so if Twist 
can be used for gene diagnosis, then this technique will 
be of important significance in enhancing the diagnostic 
accuracy of prostate cancer and determining the prognosis. 
Twist can be used as a target of tumor biotherapy, and 
inhibiting or getting rid of Twist expression using biological 
targeted therapy can achieve the purpose of prostate cancer 
treatment, providing a new thought and pathway for the 
diagnosis and treatment of prostate cancer. 
  The incidence and development of prostate cancer is a 
multi-step and multi-stage complex process. The decrease 
in adhesion between tumor cells is the first step of tumor 
cell infiltration and metastasis, and EMT contributes to 
this step. EMT is initially recognized during the process 
of embryonic development and organ formation, and it is 
generally accepted that tumor cells infiltrate and transfer 
by simulating this process. Some scholars[28] found that 
the incidence and development of prostate cancer are 
similar to the development of embryonic prostate gland 
and proposed a concept that prostate cancer re-starts the 
development of prostate gland. The pathological process of 
tumor cell infiltration and metastasis is closely related to 
EMT in prostate cancer. Abnormal expression of E-cadherin 
and N-cadherin is the most important molecular event in 
prostate cancer, and TGF-毬1and Twist play an important 
regulatory role in this process. However, the underlying 
molecular mechanism remains poorly understood and 
whether many more signal molecules participate in the 
regulation needs to be further investigated. 
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